Tomasevic-Todorovic Snezana, Vazic Atina, Issaka Abukari, Hanna Fahad
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Higher School, College of Professional Studies in Education of Teachers, Kikinda, Serbia.
Open Access Rheumatol. 2018 May 30;10:61-66. doi: 10.2147/OARRR.S151307. eCollection 2018.
Both osteoporosis and osteopenia remain worldwide public health concerns. They both lead to bone fractures, which can lead to disability and burden on those who are afflicted.
To assess and compare fracture risk between these two groups of patients.
Our cross-sectional study included 82 patients (46 with osteoporosis and 36 with osteopenia) with an average age of 63±9.33 years, who received treatment at the Clinic for Medical Rehabilitation, Clinical Center of Vojvodina in Novi Sad, Serbia. The assessment of the fracture risk was executed by applying the Fracture Assessment Risk (FRAX) index (an algorithm developed by the World Health Organization) based on clinical fracture risks or combination of clinical fracture risks and bone mineral density.
Patients with osteoporosis had significantly higher risk of major fracture compared to patients with osteopenia (<0.01). Results from FRAX index in osteoporotic patients showed that more than half (58.70%) of patients had a low risk of fracture; less than one-third of patients (30.43%) had an intermediate risk of major osteoporotic fracture, while almost four out of every 10 (39.96%) had a high risk of hip fracture. The majority of patients with osteopenia (63.89%) had a low risk of major osteoporotic fracture, while 36.11% of them had an intermediate risk. The majority of patients with osteopenia (91.67%) had a low risk of hip fracture. Statistically significant differences in relation to specific fracture risks between patients with osteoporosis and osteopenia, in particular, weight (=-2.250, =0.027*) and previous fractures (=2.985, =0.004**), were established.
Osteoporosis patients had a high risk of major osteoporotic fracture, while there was no association between the intermediate level for major osteoporotic fracture and osteo-penia. For patients suffering from an increased fracture risk, especially those who had already been diagnosed with osteoporosis, preventive measures such as designing individual therapeutic programs should be adopted.
骨质疏松症和骨质减少仍然是全球公共卫生关注的问题。它们都会导致骨折,进而导致残疾并给患者带来负担。
评估和比较这两组患者的骨折风险。
我们的横断面研究纳入了82例患者(46例骨质疏松症患者和36例骨质减少患者),平均年龄为63±9.33岁,他们在塞尔维亚诺维萨德伏伊伏丁那临床中心医学康复诊所接受治疗。通过应用骨折评估风险(FRAX)指数(世界卫生组织开发的一种算法),基于临床骨折风险或临床骨折风险与骨密度的组合来评估骨折风险。
与骨质减少患者相比,骨质疏松症患者发生主要骨折的风险显著更高(<0.01)。骨质疏松症患者的FRAX指数结果显示,超过一半(58.70%)的患者骨折风险较低;不到三分之一的患者(30.43%)有中度骨质疏松性骨折风险,则每10人中有近4人(39.96%)有较高的髋部骨折风险。大多数骨质减少患者(63.89%)有较低的骨质疏松性骨折风险,而其中36.11%有中度风险。大多数骨质减少患者(91.67%)有较低的髋部骨折风险。确定了骨质疏松症患者和骨质减少患者在特定骨折风险方面的统计学显著差异,特别是体重(=-2.250,=0.027*)和既往骨折(=2.985,=0.004**)。
骨质疏松症患者有较高的骨质疏松性骨折风险,而中度骨质疏松性骨折水平与骨质减少之间无关联。对于骨折风险增加的患者,尤其是那些已被诊断为骨质疏松症的患者),应采取诸如制定个体化治疗方案等预防措施。